DK131760C - Fremgangsmade til fremstilling af et insulinsalt-protaminkomplex - Google Patents

Fremgangsmade til fremstilling af et insulinsalt-protaminkomplex

Info

Publication number
DK131760C
DK131760C DK209472A DK209472A DK131760C DK 131760 C DK131760 C DK 131760C DK 209472 A DK209472 A DK 209472A DK 209472 A DK209472 A DK 209472A DK 131760 C DK131760 C DK 131760C
Authority
DK
Denmark
Prior art keywords
protamin
preparing
complex
procedure
insulin salt
Prior art date
Application number
DK209472A
Other languages
Danish (da)
English (en)
Other versions
DK131760B (da
Inventor
R L Jackson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DK131760B publication Critical patent/DK131760B/da
Application granted granted Critical
Publication of DK131760C publication Critical patent/DK131760C/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK209472A 1971-04-30 1972-04-27 Fremgangsmade til fremstilling af et insulinsalt-protaminkomplex DK131760C (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13912071A 1971-04-30 1971-04-30

Publications (2)

Publication Number Publication Date
DK131760B DK131760B (da) 1975-09-01
DK131760C true DK131760C (da) 1976-02-02

Family

ID=22485216

Family Applications (1)

Application Number Title Priority Date Filing Date
DK209472A DK131760C (da) 1971-04-30 1972-04-27 Fremgangsmade til fremstilling af et insulinsalt-protaminkomplex

Country Status (23)

Country Link
US (1) US3758683A (de)
JP (1) JPS5735185B1 (de)
BE (1) BE782651A (de)
CA (1) CA976085A (de)
CH (1) CH566784A5 (de)
CS (1) CS209458B2 (de)
DD (1) DD100708A5 (de)
DE (1) DE2219635C3 (de)
DK (1) DK131760C (de)
ES (1) ES402176A1 (de)
FI (1) FI49773C (de)
FR (1) FR2134658B1 (de)
GB (1) GB1385086A (de)
HU (1) HU166989B (de)
IL (1) IL39181A (de)
NL (1) NL178258C (de)
NO (1) NO137178C (de)
PL (1) PL86966B1 (de)
RO (1) RO64387A (de)
SE (1) SE378066B (de)
SU (1) SU508162A3 (de)
YU (1) YU36155B (de)
ZA (1) ZA722243B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK140801B (da) * 1975-01-15 1979-11-19 Nordisk Insulinlab Fremgangsmåde til fremstilling af et stabilt langtidsvirkende insulinpræparat.
NL193099C (nl) * 1981-10-30 1998-11-03 Novo Industri As Gestabiliseerde insuline-oplossing.
JPH01501389A (ja) * 1986-10-20 1989-05-18 ノボ インダストリ アクティーゼルスカブ ポリペプチド製剤
NZ223630A (en) * 1987-02-25 1989-11-28 Novo Industri As Insulin derivative and pharmaceutical compositions
DE19726167B4 (de) 1997-06-20 2008-01-24 Sanofi-Aventis Deutschland Gmbh Insulin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung
US6624141B1 (en) * 1999-03-17 2003-09-23 The Regents Of The University Of Michigan Protamine fragment compositions and methods of use
DE10114178A1 (de) * 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
DE10227232A1 (de) * 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Saure Insulinzubereitungen mit verbesserter Stabilität
KR101820024B1 (ko) 2008-10-17 2018-01-18 사노피-아벤티스 도이칠란트 게엠베하 인슐린과 glp-1 효능제의 병용물
HUE037735T2 (hu) 2009-11-13 2018-09-28 Sanofi Aventis Deutschland DesPro36exendin-4(1-39)-Lys6-NH2-t és metionint tartalmazó gyógyszerkészítmény
ES2534191T3 (es) 2009-11-13 2015-04-20 Sanofi-Aventis Deutschland Gmbh Composición farmacéutica que comprende un agonista de GLP-1, una insulina y metionina
BR112013004756B1 (pt) 2010-08-30 2020-04-28 Sanofi Aventis Deutschland uso de ave0010 para a fabricação de um medicamento para o tratamento da diabetes melito tipo 2
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
RU2650616C2 (ru) 2011-08-29 2018-04-16 Санофи-Авентис Дойчланд Гмбх Фармацевтическая комбинация для применения при гликемическом контроле у пациентов с сахарным диабетом 2 типа
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
JP6970615B2 (ja) 2014-12-12 2021-11-24 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング インスリングラルギン/リキシセナチド固定比処方
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患之治療
PE20211202A1 (es) 2017-08-24 2021-07-05 Novo Nordisk As Composiciones de glp-1 y sus usos
WO2021144476A1 (en) 2020-02-18 2021-07-22 Novo Nordisk A/S Pharmaceutical formulations

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5038E (fr) * 1904-03-09 1905-12-02 Georges Frederic Brade Perfectionnements dans la fabrication des organes du métronome
GB889769A (en) * 1957-07-18 1962-02-21 Nordisk Insulinlab Slowly acting insulin preparation in crystalline form

Also Published As

Publication number Publication date
NL178258C (nl) 1986-02-17
YU114272A (en) 1981-06-30
YU36155B (en) 1982-02-25
CA976085A (en) 1975-10-14
US3758683A (en) 1973-09-11
HU166989B (de) 1975-07-28
DE2219635B2 (de) 1980-11-27
FI49773C (fi) 1975-10-10
NL7205865A (de) 1972-11-01
ZA722243B (en) 1973-11-28
FR2134658A1 (de) 1972-12-08
SU508162A3 (ru) 1976-03-25
NL178258B (nl) 1985-09-16
CH566784A5 (de) 1975-09-30
PL86966B1 (de) 1976-06-30
JPS5735185B1 (de) 1982-07-27
IL39181A (en) 1974-09-10
BE782651A (fr) 1972-10-26
IL39181A0 (en) 1972-06-28
CS209458B2 (en) 1981-12-31
DK131760B (da) 1975-09-01
FI49773B (de) 1975-06-30
DE2219635C3 (de) 1981-10-15
RO64387A (fr) 1979-07-15
NO137178C (no) 1978-01-18
ES402176A1 (es) 1975-03-01
NO137178B (no) 1977-10-10
FR2134658B1 (de) 1975-10-17
GB1385086A (en) 1975-02-26
DD100708A5 (de) 1973-10-05
DE2219635A1 (de) 1972-11-09
SE378066B (de) 1975-08-18

Similar Documents

Publication Publication Date Title
DK131760C (da) Fremgangsmade til fremstilling af et insulinsalt-protaminkomplex
DK572975A (da) Fremgangsmade til fremstilling af hidtil ukendte pyridylguanidiner
DK487475A (da) Fremgangsmade til fremstilling af vandkveldende polyalkylenoxid
DK145059C (da) Fremgangsmaade til fremstilling af 7alfa-substituerede cephalosporinforbindelser eller 6alfa-substituerede penicillinforbindelser
DK351875A (da) Fremgangsmade til fremstilling af 7-methoxy-6-thiatetracyliner
DK223175A (da) Fremgangsmade til fremstilling af pyridobenzodiazepinoner
DK132659C (da) Fremgangsmade til fremstilling af alkyl-cis-chrysanthemater
DK157032C (da) Fremgangsmaade til fremstilling af en vandig bitumenholdig emulsion
NO151585C (no) Fremgangsmaate for fremstilling 6-deoksyoksytetracyklin
DK145854C (da) Fremgangsmaade til fremstilling af bifunktionelt tvaerbundet insulin
DK154890C (da) Fremgangsmaade til fremstilling af 7beta-acylamino-7alfa-alkoxycephalosporiner
DK130745B (da) Fremgangsmåde til fremstilling af transparente copolyamider.
DK132002C (da) Fremgangsmade til fremstilling af granuler med pesticid virkning
IT966747B (it) Procedimento per preparare dinitroantrachinoni
DK135944C (da) Fremgangsmade til fremstilling af indolderivater
SE419824B (sv) Forfarande for framstellning av en insulinberedning med depaverkan
DK139521C (da) Fremgangsmaade til fremstilling af ren krystallinsk penicillinacylase
DK134183B (da) Fremgangsmåde til fremstilling af cellulose-enzymkomplekser.
DK145462C (da) Fremgangsmaade til fremstilling af 15-alkyl-prostaglandin e-forbindelser
TR18287A (tr) Triasetonamin hazirlamaya mahsus usul
DK145020C (da) Fremgangsmaade til fremstilling af 3-methyl-7-methoxy-8-dimethylaminomethyl-flavon eller et salt deraf
DK152434C (da) Fremgangsmaade til fremstilling af l-pyroglutamyl-l-histidyl-l-prolin-amid
DK133496C (da) Fremgangsmade til fremstilling af en streptokinaseholdig fibrinolyseaktivator
DK133130C (da) Fremgangsmade til fremstilling af urokinaseheparinat
DK134776C (da) Fremgangsmade til fremstilling af pseudowollastonit

Legal Events

Date Code Title Description
PBP Patent lapsed